EVerZom

EVerZom is a Paris-based biotechnology company specializing in the development of innovative exosome-based therapies.

Its mission is to unlock the therapeutic potential of these natural vesicles produced by cells, considered the next revolution in regenerative treatments. Thanks to a patented technological platform covering all stages, from exosome production to their loading and formulation, EVerZom designs new solutions to treat complex pathologies.

The company is developing therapeutic candidates intended to promote the healing of digestive tissues, such as in Crohn’s fistulas, as well as to regenerate organs such as the liver or kidneys, with anti-inflammatory and anti-fibrosis effects demonstrated in preclinical studies.

A winner of the European EIC Accelerator program, EVerZom has received significant financial support to accelerate clinical-scale production and industrialization of its treatments.